Cormorant Global Healthcare Master Fund LP 13D and 13G filings for Corbus Pharmaceuticals Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-05 4:47 pm Purchase | 2024-01-26 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP | Cormorant Global Healthcare Master Fund LP | 1,475,000 14.270% | 1,475,000 (New Position) | Filing |